http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Cho, Sang-Geon,Jabin, Zeenat,Park, Ki Seong,Kim, Jahae,Kang, Sae-Ryung,Kwon, Seong Young,Jeong, Geum-Cheol,Song, Minchul,Kim, Jong Sang,Cho, Jae Yeong,Kim, Hyun Kuk,Song, Ho-Chun,Min, Jung-Joon,Bom, H Springer-Verlag 2017 European Journal of Nuclear Medicine and Molecular Vol.44 No.2
<P>LVMD measured by GMPS showed added prognostic value in acute MI with multivessel disease. GMPS could serve as a comprehensive evaluation imaging tool in patients with acute MI and multivessel disease.</P>
송민철,정수빈,강세령,zeenat jabin,유수웅,민정준,범희승,조상건,김자혜,송호천,권성영 대한핵의학회 2018 핵의학 분자영상 Vol.52 No.4
Purpose Thyroglobulin (Tg) may be released from damaged residual thyroid tissues after radioactive iodine (RAI) therapy inpatients with differentiated thyroid carcinoma (DTC). We investigated whether altered levels of serum Tg after recombinanthuman thyrotropin (rhTSH)-aided RAI therapy could be a prognostic marker in patients with DTC. Methods We evaluated 68 patients who underwent RAI therapy after total thyroidectomy. Serum Tg levels were measured justbefore RAI administration (D0Tg) and 7 days after RAI therapy (D7Tg). Patients with a D0Tg level greater than 2.0 ng/mL wereexcluded to more precisely evaluate the injury effect of RAI in small remnant tissues. The ratioTg was defined as the D7Tg leveldivided by that on D0Tg. The therapeutic responses were classified as acceptable or non-acceptable. Finally, we investigatedwhich clinicopathologic parameters were associated with therapeutic response. Results At the follow-up examination, an acceptable response was observed in 50 patients (73.5%). Univariate analysis revealedsignificant differences in N stage (P = 0.003) and ratioTg (acceptable vs. non-acceptable responses, 21.9 ± 33.6 vs. 3.8 ± 6.5; P =0.006). In multivariate analysis, only ratioTg significantly predicted an acceptable response (odds ratio 1.104; 95% confidenceinterval 1.005–1.213; P = 0.040). A ratioTg above 3.5 predicted an acceptable response with a sensitivity of 66.0%, specificity of83.3%, and accuracy of 70.6% (area under the curve = 0.718; P = 0.006). Conclusions Altered levels of serum Tg after RAI therapy, calculated as the ratioTg (D7Tg/D0Tg), significantly predicted anacceptable response in patients with DTC.
유수웅,Sunny Anam Chowdhury,전수빈,강세령,이창호,Jabin Zeenat,김자혜,조상건,송호천,범희승,민정준,권성영 대한핵의학회 2020 핵의학 분자영상 Vol.54 No.4
Purpose We investigated the clinical role of F-18 fluorodeoxyglucose (FDG) positron emission tomography-computed tomography (PET-CT) in the identification of the primary site and the selection of the optimal biopsy site in patients with suspected bone metastasis of unknown primary site. Methods The patients with suspected bone metastasis who underwent PET-CT for evaluation of primary site were enrolled in this study. The primary sites were identified by the histopathologic or imaging studies and were classified according to the FDG uptake positivity of the primary site. To evaluate the guiding capability of PET-CT in biopsy site selection, we statistically analyzed whether the biopsy site could be affected according to the presence of extra-skeletal FDG uptake. Results Among 74 enrolled patients, 51 patients had a metastatic bone disease. The primary site was identified in 48 of 51 patients (94.1%). Forty-six patients were eligible to test the association of clinical choice of biopsy site with PET positivity of extra-skeletal lesion. The extra-skeletal biopsies were done in 42 out of 43 patients with positive extra-skeletal uptake lesions. Bone biopsies were inevitably performed in the other three patients without extra-skeletal uptake lesions. The association came out to be significant (Fisher’s exact test, P < 0.001). Conclusion F-18 FDG PET-CT significantly contributed not only to identify the primary site but also to suggest optimal biopsy sites in patients with suspected bone metastasis.